´╗┐Subjects were immunized with 2, 4, or 8?mg of pHM-GM-CSF at weeks 0, 2, and 4 and then boosted with 3??109 VP of Ad-HM at week 6

´╗┐Subjects were immunized with 2, 4, or 8?mg of pHM-GM-CSF at weeks 0, 2, and 4 and then boosted with 3??109 VP of Ad-HM at week 6. of BMS-1166 hydrochloride small grade 1 toxicities in four of nine subjects and no severe drug-related AEs were reported. HER2-specific cell-mediated or humoral immunity was produced in all …
Continue reading ´╗┐Subjects were immunized with 2, 4, or 8?mg of pHM-GM-CSF at weeks 0, 2, and 4 and then boosted with 3??109 VP of Ad-HM at week 6